Search: 
You do not have permission to access this chart.
Please Sign Up or Login
News for Kaleido Biosciences, Inc. (KLDO)
Newly released Crypto mining rig for Kaleido Biosciences, Inc. coins
minutes ago | Banggood.com
Everything Crypto on sale now!
58 minutes ago | Aliexpress.com
Kaleido Biosciences, Inc. (KLDO) Reports Q2 Loss, Lags Revenue Estimates
4 days ago | Zacks Investment Research
Kaleido Biosciences Reports Second Quarter 2021 Financial Results
4 days ago | GlobeNewsWire
Kaleido Biosciences and the COPD Foundation Announce a Strategic Collaboration to Advance KB109 into Phase 2 Clinical Trial
5 days ago | GlobeNewsWire
Kaleido Biosciences Announces New Chairperson Appointment to its Board of Directors
5 days ago | GlobeNewsWire
Kaleido Biosciences to Participate in the 41st Annual Canaccord Genuity Growth Conference
a week ago | GlobeNewsWire
Kaleido Biosciences, Inc. (KLDO) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
2 weeks ago | Zacks Investment Research
Kaleido Biosciences to Participate in the JMP Securities Life Sciences Conference
2 months ago | GlobeNewsWire
Kaleido Biosciences Reports First Quarter 2021 Financial Results
3 months ago | GlobeNewsWire
Kaleido Biosciences Announces Collaboration with Robert Jenq, M.D., to Explore Potential of its Microbiome Metabolic Therapies (MMT™) in Preventing Febrile Neutropenia
3 months ago | GlobeNewsWire
Kaleido Biosciences to Participate in Jefferies Microbiome-Based Therapeutics Summit
4 months ago | GlobeNewsWire

About:

Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the treatment of immuno-oncology, and cardiometabolic and liver diseases. The company has collaboration agreements with Gustave Roussy Cancer Center, Washington University School of Medicine, and Janssen. The company was incorporated in 2015 and is headquartered in Lexington, Massachusetts.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

82

Address:

Kaleido Biosciences, Inc. 65 Hayden Avenue Lexington MA 02421 United States

Website:

http://kaleido.com

Phone:

617-674-9000

Leave a comment

Your email address will not be published. Required fields are marked *